Abstract:Background: Accumulating evidence has suggested that glycometabolism plays an important role in the pathogenesis of tumorigenesis. However, few studies have investigated the prognostic values of glycometabolic genes in patients with osteosarcoma (OS). This study aimed to recognize and establish a glycometabolic gene signature to forecast the prognosis, and provide therapeutic options for patients with OS. Methods: Univariate and multivariate Cox regression, LASSO Cox regression, overall survival analysis, receiver operating characteristic curve, and nomogram were adopted to develop the glycometabolic gene signature, and further evaluate the prognostic values of this signature. Functional analyses including Gene Ontology (GO), kyoto encyclopedia of genes and genomes analyses (KEGG), gene set enrichment analysis, single-sample gene set enrichment analysis (ssGSEA), and competing endogenous RNA (ceRNA) network, were used to explore the molecular mechanisms of OS and the correlation between immune infiltration and gene signature. Moreover, these prognostic genes were further validated by immunohistochemical staining. Results: A total of four genes including PRKACB, SEPHS2, GPX7, and PFKFB3 were identified for constructing a glycometabolic gene signature which had a favorable performance in predicting the prognosis of patients with OS. Univariate and multivariate Cox regression analyses revealed that the risk score was an independent prognostic factor. Functional analyses indicated that multiple immune associated biological processes and pathways were enriched in the low-risk group, while 26 immunocytes were down-regulated in the high-risk group. The patients in high-risk group showed elevated sensitivity to doxorubicin. Furthermore, these prognostic genes could directly or indirectly interact with other 50 genes. A ceRNA regulatory network based on these prognostic genes was also constructed. The results of immunohistochemical staining showed that SEPHS2, GPX7, and PFKFB3 were differentially expressed between OS tissues and adjacent normal tissues. Conclusion: The preset study constructed and validated a novel glycometabolic gene signature which could predict the prognosis of patients with OS, identify the degree of immune infiltration in tumor microenvironment, and provide guidance for the selection of chemotherapeutic drugs. These findings may shed new light on the investigation of molecular mechanisms and comprehensive treatments for OS.

OSmfs: An Online Interactive Tool to Evaluate Prognostic Markers for Myxofibrosarcoma

MCAM is Associated with Metastasis and Poor Prognosis in Osteosarcoma by Modulating Tumor Cell Migration

Identification of a Programmed Cell Death-related Signature for Prediction of Osteosarcoma

OSlms: A Web Server to Evaluate the Prognostic Value of Genes in Leiomyosarcoma.

Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma

OSskcm: an online survival analysis webserver for skin cutaneous melanoma based on 1085 transcriptomic profiles

A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma

Comprehensive Analysis of Copper-Metabolism-related Genes about Prognosis and Immune Microenvironment in Osteosarcoma

Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature

A Web-Based Calculator for Predicting the Prognosis of Patients with Sarcoma on the Basis of Antioxidant Gene Signatures.

Identification and Analysis of Three Hub Prognostic Genes Related to Osteosarcoma Metastasis

OSgc: A Web Portal to Assess the Performance of Prognostic Biomarkers in Gastric Cancer

OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma

Employing machine learning using ferroptosis-related genes to construct a prognosis model for patients with osteosarcoma

Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma

TRIM68, PIKFYVE, and DYNLL2: The Possible Novel Autophagy- and Immunity-Associated Gene Biomarkers for Osteosarcoma Prognosis

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma

Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis

Development and Validation of a Prognostic Nomogram for Predicting the Overall Survival of Myxofibrosarcoma Patients: a Large Population-Based Study

Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated with Osteosarcoma Microenvironment